Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Lancelot ULLENS, Director. Officer active across 1 company, notably Octopus Biosafety. Aggregated, 1 reports have been published. Activity tracked since 28 July 2023. The latest transaction was disclosed on 28 July 2023 (Souscription). Regulator: AMF. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Lancelot Ullens is a Board Member at Octopus Biosafety. He participates in strategic decisions and governance of the company, bringing his expertise in the field of biosafety. His role is crucial for the development and growth of Octopus.